annual accounts payable:
$6.00M+$400.00K(+7.14%)Summary
- As of today (August 17, 2025), UTHR annual accounts payable is $6.00 million, with the most recent change of +$400.00 thousand (+7.14%) on December 31, 2024.
- During the last 3 years, UTHR annual accounts payable has risen by +$2.20 million (+57.89%).
- UTHR annual accounts payable is now -87.30% below its all-time high of $47.26 million, reached on December 31, 2011.
Performance
UTHR Accounts payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly accounts payable:
$432.00M+$65.00M(+17.71%)Summary
- As of today (August 17, 2025), UTHR quarterly accounts payable is $432.00 million, with the most recent change of +$65.00 million (+17.71%) on June 30, 2025.
- Over the past year, UTHR quarterly accounts payable has increased by +$106.70 million (+32.80%).
- UTHR quarterly accounts payable is now at all-time high.
Performance
UTHR quarterly accounts payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Accounts payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
UTHR Accounts payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +7.1% | +32.8% |
| 3 y3 years | +57.9% | +119.7% |
| 5 y5 years | -39.4% | +183.1% |
UTHR Accounts payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +57.9% | at high | +7100.0% |
| 5 y | 5-year | -39.4% | +57.9% | at high | >+9999.0% |
| alltime | all time | -87.3% | +252.9% | at high | >+9999.0% |
UTHR Accounts payable History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $432.00M(+17.7%) |
| Mar 2025 | - | $367.00M(+6016.7%) |
| Dec 2024 | $6.00M(+7.1%) | $6.00M(-98.4%) |
| Sep 2024 | - | $363.90M(+11.9%) |
| Jun 2024 | - | $325.30M(+6.6%) |
| Mar 2024 | - | $305.10M(+2.4%) |
| Dec 2023 | $5.60M(+36.6%) | $298.00M(-10.6%) |
| Sep 2023 | - | $333.40M(+14.2%) |
| Jun 2023 | - | $292.00M(+21.8%) |
| Mar 2023 | - | $239.70M(+4.3%) |
| Dec 2022 | $4.10M(+7.9%) | $229.90M(+4.5%) |
| Sep 2022 | - | $220.10M(+12.0%) |
| Jun 2022 | - | $196.60M(+18.1%) |
| Mar 2022 | - | $166.40M(+4278.9%) |
| Dec 2021 | $3.80M(-7.3%) | $3.80M(-98.2%) |
| Sep 2021 | - | $210.50M(+10.9%) |
| Jun 2021 | - | $189.80M(+15.0%) |
| Mar 2021 | - | $165.00M(+3924.4%) |
| Dec 2020 | $4.10M(-58.6%) | $4.10M(-97.7%) |
| Sep 2020 | - | $177.10M(+16.1%) |
| Jun 2020 | - | $152.60M(+17.1%) |
| Mar 2020 | - | $130.30M(-12.2%) |
| Dec 2019 | $9.90M(-57.1%) | $148.40M(-7.9%) |
| Sep 2019 | - | $161.10M(-1.7%) |
| Jun 2019 | - | $163.90M(+17.6%) |
| Mar 2019 | - | $139.40M(-16.1%) |
| Dec 2018 | $23.10M(+175.0%) | $166.10M(-18.9%) |
| Sep 2018 | - | $204.80M(-5.2%) |
| Jun 2018 | - | $216.00M(+6.2%) |
| Mar 2018 | - | $203.40M(+18.9%) |
| Dec 2017 | $8.40M(+3.7%) | $171.10M(+19.4%) |
| Sep 2017 | - | $143.30M(+13.0%) |
| Jun 2017 | - | $126.80M(+20.1%) |
| Mar 2017 | - | $105.60M(+1.3%) |
| Dec 2016 | $8.10M(+8.0%) | $104.20M(-12.4%) |
| Sep 2016 | - | $119.00M(-4.0%) |
| Jun 2016 | - | $124.00M(+16.3%) |
| Mar 2016 | - | $106.60M(+3.1%) |
| Dec 2015 | $7.50M(+7.2%) | $103.43M(-8.7%) |
| Sep 2015 | - | $113.35M(+2.9%) |
| Jun 2015 | - | $110.11M(+22.2%) |
| Mar 2015 | - | $90.13M(+5.6%) |
| Dec 2014 | $7.00M(+4.3%) | $85.38M(-33.3%) |
| Sep 2014 | - | $127.96M(+14.0%) |
| Jun 2014 | - | $112.25M(+7.9%) |
| Mar 2014 | - | $104.02M(+12.8%) |
| Dec 2013 | $6.71M(-34.3%) | $92.24M(-5.4%) |
| Sep 2013 | - | $97.51M(+939.9%) |
| Jun 2013 | - | $9.38M(-8.0%) |
| Mar 2013 | - | $10.19M(-0.1%) |
| Dec 2012 | $10.20M | $10.20M(+0.7%) |
| Sep 2012 | - | $10.13M(+16.5%) |
| Jun 2012 | - | $8.70M(+4.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2012 | - | $8.34M(-82.4%) |
| Dec 2011 | $47.26M(+192.7%) | $47.26M(+174.0%) |
| Sep 2011 | - | $17.24M(+0.9%) |
| Jun 2011 | - | $17.08M(+70.2%) |
| Mar 2011 | - | $10.04M(-37.8%) |
| Dec 2010 | $16.15M(-13.9%) | $16.15M(+42.9%) |
| Sep 2010 | - | $11.30M(+20.8%) |
| Jun 2010 | - | $9.35M(+42.7%) |
| Mar 2010 | - | $6.55M(-65.1%) |
| Dec 2009 | $18.75M(-7.8%) | $18.75M(+6.0%) |
| Sep 2009 | - | $17.69M(-10.2%) |
| Jun 2009 | - | $19.70M(+87.4%) |
| Mar 2009 | - | $10.51M(-48.3%) |
| Dec 2008 | $20.33M(+916.7%) | $20.33M(+26.2%) |
| Sep 2008 | - | $16.11M(+9.1%) |
| Jun 2008 | - | $14.77M(-10.3%) |
| Mar 2008 | - | $16.48M(+723.8%) |
| Dec 2007 | $2.00M(-35.3%) | $2.00M(-85.7%) |
| Sep 2007 | - | $13.99M(+174.6%) |
| Jun 2007 | - | $5.10M(+2.6%) |
| Mar 2007 | - | $4.97M(+74.7%) |
| Dec 2006 | $3.09M(-22.3%) | $2.84M(-22.1%) |
| Sep 2006 | - | $3.65M(-16.3%) |
| Jun 2006 | - | $4.36M(-6.7%) |
| Mar 2006 | - | $4.67M(+17.6%) |
| Dec 2005 | $3.98M(-35.0%) | $3.97M(-2.2%) |
| Sep 2005 | - | $4.06M(+2.8%) |
| Jun 2005 | - | $3.95M(+31.9%) |
| Mar 2005 | - | $3.00M(-50.9%) |
| Dec 2004 | $6.13M(+41.6%) | $6.10M(+129.2%) |
| Sep 2004 | - | $2.66M(+0.7%) |
| Jun 2004 | - | $2.64M(-20.8%) |
| Mar 2004 | - | $3.34M(-22.8%) |
| Dec 2003 | $4.33M(+44.8%) | $4.32M(-2.0%) |
| Sep 2003 | - | $4.41M(+44.4%) |
| Jun 2003 | - | $3.06M(+8.8%) |
| Mar 2003 | - | $2.81M(-6.0%) |
| Dec 2002 | $2.99M(-55.2%) | $2.99M(-49.0%) |
| Sep 2002 | - | $5.86M(-1.2%) |
| Jun 2002 | - | $5.93M(+73.1%) |
| Mar 2002 | - | $3.43M(-48.6%) |
| Dec 2001 | $6.67M(+12.0%) | $6.67M(+28.9%) |
| Sep 2001 | - | $5.17M(-15.2%) |
| Jun 2001 | - | $6.10M(-12.4%) |
| Mar 2001 | - | $6.96M(+16.9%) |
| Dec 2000 | $5.95M(+158.8%) | $5.95M(+78.8%) |
| Sep 2000 | - | $3.33M(-0.4%) |
| Jun 2000 | - | $3.34M(+16.2%) |
| Mar 2000 | - | $2.88M(+22.5%) |
| Dec 1999 | $2.30M(+35.3%) | $2.35M(+8.6%) |
| Sep 1999 | - | $2.16M(+191.8%) |
| Jun 1999 | - | $741.00K(-57.3%) |
| Mar 1999 | - | $1.74M |
| Dec 1998 | $1.70M | - |
FAQ
- What is United Therapeutics Corporation annual accounts payable?
- What is the all time high annual accounts payable for United Therapeutics Corporation?
- What is United Therapeutics Corporation annual accounts payable year-on-year change?
- What is United Therapeutics Corporation quarterly accounts payable?
- What is the all time high quarterly accounts payable for United Therapeutics Corporation?
- What is United Therapeutics Corporation quarterly accounts payable year-on-year change?
What is United Therapeutics Corporation annual accounts payable?
The current annual accounts payable of UTHR is $6.00M
What is the all time high annual accounts payable for United Therapeutics Corporation?
United Therapeutics Corporation all-time high annual accounts payable is $47.26M
What is United Therapeutics Corporation annual accounts payable year-on-year change?
Over the past year, UTHR annual accounts payable has changed by +$400.00K (+7.14%)
What is United Therapeutics Corporation quarterly accounts payable?
The current quarterly accounts payable of UTHR is $432.00M
What is the all time high quarterly accounts payable for United Therapeutics Corporation?
United Therapeutics Corporation all-time high quarterly accounts payable is $432.00M
What is United Therapeutics Corporation quarterly accounts payable year-on-year change?
Over the past year, UTHR quarterly accounts payable has changed by +$106.70M (+32.80%)